98 related articles for article (PubMed ID: 2169644)
1. Structure and function of rat parietal cells during treatment with omeprazole, SCH 28080, SCH 32651, or ranitidine.
Helander HF; Mattsson H; Elm G; Ottosson S
Scand J Gastroenterol; 1990 Aug; 25(8):799-809. PubMed ID: 2169644
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of H+K+ATPase by SCH 28080 and SCH 32651.
Scott CK; Sundell E
Eur J Pharmacol; 1985 Jun; 112(2):268-70. PubMed ID: 2993001
[TBL] [Abstract][Full Text] [Related]
3. SCH 28080 is a more selective inhibitor than SCH 32651 at the K+ site of gastric K+/H+-ATPase.
Beil W; Staar U; Sewing KF
Eur J Pharmacol; 1987 Jul; 139(3):349-52. PubMed ID: 2822435
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
Batzri S; Brugada O; Harmon JW; Rich NM
J Pharmacol Exp Ther; 1988 Aug; 246(2):493-9. PubMed ID: 2841448
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of H+,K+-ATPase by methyl(E)-2-(3,4-dimethoxystyryl)-benzimidazole-4-carboxylate (ALE-36).
Yamamoto O; Tanaka H; Ueda F; Kimura K
Scand J Gastroenterol Suppl; 1989; 162():178-81. PubMed ID: 2556788
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole, SCH 28080 and doxepin differ in their characteristics to inhibit H+/K+-ATPase driven proton accumulation by parietal cell membrane vesicles.
Beil W; Staar U; Schünemann P; Sewing KF
Biochem Pharmacol; 1988 Dec; 37(23):4487-93. PubMed ID: 2849447
[TBL] [Abstract][Full Text] [Related]
7. Parietal cell kinetics after administration of omeprazole and ranitidine in the rat.
Li H; Helander HF
Scand J Gastroenterol; 1995 Mar; 30(3):205-9. PubMed ID: 7770707
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
Lamers CB
Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019
[No Abstract] [Full Text] [Related]
9. Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080.
Scott CK; Sundell E; Castrovilly L
Biochem Pharmacol; 1987 Jan; 36(1):97-104. PubMed ID: 3026407
[TBL] [Abstract][Full Text] [Related]
10. Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion.
Gedda K; Scott D; Besancon M; Lorentzon P; Sachs G
Gastroenterology; 1995 Oct; 109(4):1134-41. PubMed ID: 7557078
[TBL] [Abstract][Full Text] [Related]
11. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.
Larsson H; Carlsson E; Mattsson H; Lundell L; Sundler F; Sundell G; Wallmark B; Watanabe T; Håkanson R
Gastroenterology; 1986 Feb; 90(2):391-9. PubMed ID: 3510144
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.
Driman DK; Wright C; Tougas G; Riddell RH
Dig Dis Sci; 1996 Oct; 41(10):2039-47. PubMed ID: 8888719
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole: mode of action and effect on acid secretion in animals.
Wallmark B
Scand J Gastroenterol Suppl; 1989; 166():12-8. PubMed ID: 2557668
[TBL] [Abstract][Full Text] [Related]
14. Effects of omeprazole and ranitidine on gastric acid secretion, blood gastrin levels and [3H]-thymidine incorporation in the oxyntic mucosa from dogs and rats.
Ryberg B; Mattsson H; Carlsson E
Digestion; 1988; 39(2):91-9. PubMed ID: 3410171
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells.
Stachura J; Konturek SJ; Cieszkowsky M; Dabroś W; Zakrzewska J; Konturek J
Hepatogastroenterology; 1983 Oct; 30(5):205-10. PubMed ID: 6315556
[TBL] [Abstract][Full Text] [Related]
16. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
Nagaya H; Satoh H
Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological agents of gastric acid secretion: receptor antagonists and pump inhibitors.
Wallmark B; Fryklund J
Methods Enzymol; 1990; 191():721-38. PubMed ID: 1963658
[No Abstract] [Full Text] [Related]
18. Rat parietal cell function after prolonged inhibition of gastric acid secretion.
Larsson H; Carlsson E; Ryberg B; Fryklund J; Wallmark B
Am J Physiol; 1988 Jan; 254(1 Pt 1):G33-9. PubMed ID: 2827515
[TBL] [Abstract][Full Text] [Related]
19. Effects of SCH 32651 on resting and stimulated acid secretion in guinea-pig isolated fundic mucosa.
Barnett A; Chiu PJ; Tetzloff G
Br J Pharmacol; 1984 Sep; 83(1):75-82. PubMed ID: 6091829
[TBL] [Abstract][Full Text] [Related]
20. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]